Tratamento com bioterápico Candida albicans influencia a adesão de fungos a células Ma104 in vitro / Treatment with Candida albicans biotherapic influences in vitro fungal adhesion to Ma-104 cells
Costa, Beatriz Guerreiro Basílio; Siqueira, Camila Monteiro; Barbosa, Gleyce Moreno; da Veiga, Venicio Feo; Portela, Maristela Barbosa; Soares, Rosangela Maria de Araújo; Holandino, Carla.
Int. j. high dilution res
; 10(36): 152-154, september 30, 2011.
Artículo
en Inglés
|
LILACS-Express
| ID: hom-10715
Oral candidiasis is an opportunist fungal infection in humans, mainly caused by Candida albicans. It occurs when the host presents an imbalance in the immune system and Candida spp., normally found in human flora, become able to develop the infection [1]. This disease is very common in HIV patients, and in all individuals that present immunossupression, such as patients treated with chemotherapy. Considering this scenario, the development of new medicines to treat oral candidiasis is mandatory.These results showed that the biotherapic did not present any citotoxicity, but was able to modify the morphological aspects of Ma-104 cells. Additionally, the interaction between host cells and ethilogic agent is directly influenced by biotherapic treatment, suggesting a promising antifungal potential of this medicine.(AU)
Biblioteca responsable:
BR1.1
Texto completo
Documentos relacionados
